The growth of this market is driven by factors such as the rising demand for monoclonal bodies, the increasing prevalence of chronic diseases, funding for cell-based research, and an increase in R&D spending in the life science sector. Furthermore, the growing adoption of 3D cell culture, the growth potential of personalized medicine, and emerging economies are expected to provide significant opportunities for the growth of this market.